Search

Author/Creator Mahoney, Michelle R

1. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). (February 2021)

Authors:
Basch, Ethan; Becker, Claus; Rogak, Lauren J; Schrag, Deborah; Reeve, Bryce B; Spears, Patricia; Smith, Mary Lou; Gounder, Mrinal M; Mahoney, Michelle R; Schwartz, Gary K; Bennett, Antonia V; Mendoza, Tito R; Cleeland, Charles S; Sloan, Jeff A; Bruner, Deborah Watkins; Schwab, Gisela; Atkinson, T...
Journal:
Clinical trials
Issue:
Volume 18:Number 1(2021)
Page Start:
104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Issue 3 (March 2018)

Authors:
D'Angelo, Sandra P; Mahoney, Michelle R; Van Tine, Brian A; Atkins, James; Milhem, Mohammed M; Jahagirdar, Balkrishna N; Antonescu, Cristina R; Horvath, Elise; Tap, William D; Schwartz, Gary K; Streicher, Howard
Journal:
Lancet oncology
Issue:
Volume 19:Issue 3(2018)
Page Start:
416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search